Sanofi Buys Dynavax for $2.2B, Gains Hepatitis B Vaccine
Markets & Money Today | 2 Min News | The Daily News Now! - Un pódcast de The Daily News Now! - Martes
Categorías:
Sanofi Acquires Dynavax for $2.2B, Gains Hepatitis B Vaccine and Experimental Shingles Treatment: Despite U.S. Vaccine Challenges and FDA RejectionThe Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.
